Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]

Cardiology General

Resuscitation Efforts Impact Survival After Cardiac Arrest

Nov 20, 2012

Systematically increasing the duration of resuscitation in patients with cardiac arrest may improve survival, according to American investigators. The average duration of resuscitation was 12 minutes ...

FDA Approves Pump for Heart Failure Patients Awaiting Heart Transplant

Nov 20, 2012

The U.S. Food and Drug Administration today approved the HeartWare Ventricular Assist System, a left ventricular assist device (LVAD), to support heart function and blood flow in patients with end-sta...

Anticoagulants & Preventing Stroke in Atrial Fibrillation

Nov 20, 2012

Depending on a patient’s comorbidities and history of prior cerebrovascular events, the rate of stroke among adults with atrial fibrillation (AF) varies widely, ranging between 1% and 20% annually. ...

Unrecognized Myocardial Infarction Common in Older Adults

Nov 19, 2012

The prevalence of unrecognized myocardial infarction (MI) by cardiac MRI appears to be higher than that of community-dwelling older adults. Icelandic researchers found that 9.7% of participants had re...

The Effect of Slightly Elevated Albumin

Nov 19, 2012

Any degree of measurable albuminuria appears to bear significant cardiovascular risk among normoalbuminuric patients with type 2 diabetes, according to results of a small study. Albuminuria levels of ...

Recommendations Unveiled for Obesity Screening & Management

Nov 19, 2012

The United States Preventive Services Task Force has release a recommendation statement on screening for obesity and managing the condition in adults. Available for free at http://annals.org, the stat...

2012 VEITHsymposium: Pros and Cons of Multilayer Stent Technology to be Debated

Nov 16, 2012

Belgian Device Being Marketed in E.U., Still Awaiting U.S. Approval. The multilayer stent system for aneurysm repair developed by Belgian device-maker Cardiatis, which was approved for use in Eur...

2012 VEITHsymposium: New Medicines, New Technologies Provide Vascular Surgeons Expanded Options for Treatment of Pulmonary Embolism

Nov 16, 2012

Vascular specialists are heralding a variety of advances in the treatment of pulmonary embolism (i.e., a blood clot in a major artery in the lungs), a number of which will be presented today at the 39...

2012 VEITHsymposium: New Techniques and New Technologies in the Endovascular Arena

Nov 16, 2012

New techniques and endovascular technologies will be in the spotlight during the 39th annual VEITHsymposium for Vascular & Endovascular Issues, Techniques and Horizons, scheduled for Nov. 14-18 at...

2012 VEITHsymposium: Minimally Invasive Procedures for Aortic Aneurysm Repair

Nov 16, 2012

Experts Present New Stenting Techniques Using “Off the Shelf” Devices, Will Combine Good Outcomes with Reduced Costs. New endovascular grafting techniques to repair tissue following abdominal...

2012 VEITHsymposium: Effective Endovascular Treatments of Ruptured Abdominal Aortic Aneurysms

Nov 16, 2012

Discussions on the Value and Necessity of Level 1 Evidence The treatment of abdominal aortic aneurysms (AAAs), ruptures of which carry one of the highest mortality rates among all medical maladi...

2012 VEITHsymposium: Long-Term Patency Rates With SFA Stents

Nov 16, 2012

The Particulars: Previous research has not established the success rate for stenting of the superficial femoral artery (SFA). Data Breakdown: An investigation conducted in Germany was performed, in...

2012 VEITHsymposium: Controversial Surgical Treatment for Multiple Sclerosis

Nov 15, 2012

Chronic Cerebrovenous Insufficiency Remains a Diagnosis in Question. In 2010, Italian vascular surgeon Paolo Zamboni and his research team set off a flurry of excitement and optimism in the multi...

FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease

Nov 15, 2012

The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (fem...

Optimal Surgery Times After PCI

Nov 15, 2012

A Canadian investigation of more than 8,000 patients who underwent major elective non-cardiac surgery and received PCI within 10 years suggests that the earliest optimal time for their surgery is 46 t...

Primary Prevention ICDs Yield Survival Benefits

Nov 15, 2012

Among eligible patients, those who undergo implantable cardioverter-defibrillator (ICD) implantation appear to benefit from a significantly decreased mortality rate when compared with those who do not...

Improving Survival After Heart Failure

Nov 15, 2012

Heart failure (HF) is among the leading causes of hospitalization in the United States, afflicting more than 5.8 million men and women each year. The disease has been associated with substantial morbi...

2012 VEITHsymposium: Simplifying Aortic Arch Repair

Nov 15, 2012

The Particulars: Among patients with an inadequate proximal landing zone and/or severe angles complex configuration, an endograft fabricated based on preoperative three-dimensional CT images may allow...

2012 VEITHsymposium: Analyzing Hybrid Treatment of Aortic Arch Aneurysms

Nov 15, 2012

The Particulars: Hybrid repair of aortic arch aneurysms—in which supra-aortic trunks are rerouted and aortic endografts are deployed—has been an appealing option for patients who are not candidate...

2012 VEITHsymposium: An Alternative for AAA Repair

Nov 15, 2012

The Particulars: Alternatives to open surgery for abdominal aortic aneurysms (AAAs) are needed when adequate neck does not exist to allow for standard endovascular repair. Fenestrated endovascular rep...